Advancing Cell & Gene Therapy Development & Manufacturing

Our mission is to continuously improve patient access to breakthrough regenerative medicine by improving the speed, cost and quality of developing and manufacturing clinical grade material.
Setting the Stage for Successful Clinical Manufacturing
Download BioCentriq's new eBook Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies.

Includes five chapters of actionable advice on how to ensure quality, improve patient access, and reduce the cost of manufacturing. Discover how to objectively assess your product’s GMP-readiness and save time and money along the way.

Request Your Copy Now!

A Collaborative Cell Therapy CDMO

BioCentriq is a full-service, collaborative CDMO for cell and gene therapy, supporting all stages of process development and clinical manufacturing.

We employ expert scientists, engineers, analysts, and manufacturing specialists.  Our established, phase appropriate quality systems and newly constructed facilities are designed to support the release of autologous and allogeneic drug products. In fact, BioCentriq has been manufacturing drug products for use in human trials since 2022. 

In additional to custom development and manufacturing services, BioCentriq offers it's LEAPTM Advanced Therapy Platform which is designed to help early-stage biotech companies go from contract to clinic in as short as six months.

 

Learn More
Image

Get to know BioCentriq and experience the innovative, open, collaborative, highly attentive and pragmatic approach we bring to every project.

Download our Brochure
Image

What we do

Our goal is to advance cell therapy manufacturing to make life altering medicines and therapeutics more accessible to patients.

We work with small and medium-sized biotech companies who need process development, CMC support for an IND submission, or manufacturing supplies for use in clinical trials.

Image

How we do it

BioCentriq's process development and MS&T teams specialize in helping small and mid-size biotech optimize and scale their therapies for clinical manufacturing.

Our process is designed to be highly collaborative with lots of opportunities for virtual and on-site participation. We also offer a rapid tech transfer that prioritizes speed to help you get to clinic faster.
Image

Who we work with

In addition to offering support to small and medium-sized biotech's, we offer workforce development, process development and manufacturing support for big pharma.

We also lead technology application projects that explore and validate the potential impact when novel and emerging technologies are applied during the manufacturing process.

Image

What we do

Our goal is to advance the manufacturing of cell and gene therapies to make them more accessible to patients. Our clients are small and medium-sized biotech companies who are preparing for an IND submission or their Phase 1 industry-sponsored clinical trial.

We also have clients who manufactured their Phase 1 or Phase 2 material elsewhere and because of our expertise, transferred their technology to BioCentriq to manufacture supplies for their upcoming Phase 2 or Phase 3 trial.

Read More
Image

How we do it

Our process development and MSAT (Manufacturing Science and Technology) teams specialize in helping small and mid-size biotech optimize and scale their cell and gene therapies for clinical manufacturing.

Our tech transfer process is also designed to be highly collaborative for client teams who want to join us on site at every stage. Our facilities, infrastructure, people, quality systems and regulatory services are prepared to support commercial manufacturing.
Read More
Image

Who we work with

We also work with big pharma and technology developers on workforce development programs that support the cell and gene industry as well as technology application projects that explore the potential impact when novel and emerging technologies are applied during the manufacturing process. Lastly, on behalf of McKinsey & Partners, we operate the only Digital Capability Center focused on life sciences.
Read More

    Why BioCentriq

    Image
    Optional High-Touch Service Model
    Image
    Deep Expertise in Process Development, Analytical Methods and MS&T
    Image
    Newly Constructed Modern GMP Facilities
    Image
    Phase-Appropriate Quality Systems
    Image
    Client Maintains Ownership of IP Including Process Improvements
    Image
    Currently Manufacturing Products for Human Clinical Trials
    Image
    Experienced and Expert Regulatory Advisory Services for CGT
    Image
    High Levels of Customer Satisfaction and Flexible Contracting
    Contact Us

    Latest updates

    From Presentations to Roundtable Discussions and Interviews, It Was Hard to Miss BioCentriq at ISCT Paris 2023 

    June 8, 2023

    BioCentriq Hosts Cohort from Bpeace Pharma Maximizer Program 

    June 7, 2023

    BioCentriq™ and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing 

    June 6, 2023

    BioCentriq Hosts Cohort from Bpeace Pharma Maximizer Program 

    June 7, 2023

    BioCentriq™ and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing 

    June 6, 2023

    BioCentriq® Launches LEAP™ Advanced Therapy Platform with Proven Assets and Expertise that Help Early-Stage BioTech Companies Reach Patients in Record Time

    June 1, 2023

    BioCentriq in the news

    SEE MORE

    Upcoming events

    SEE ALL EVENTS

    Join our team

    We are looking for passionate and driven individuals with a background in cell and gene therapy to join our growing team. If you thrive in a fast-paced, always evolving environment and embrace the mission of making cell and gene therapies accessible to the patients who need them, we want to hear from you! Please browse our current job listings or contact our HR team.

    SEE ALL LISTINGS

    Get In Touch

    • This field is for validation purposes and should be left unchanged.